Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II)

Autor: Elise M Meima-van Praag, Kyra L van Rijn, Karin A T G M Wasmann, Harmanna J Snijder, Jaap Stoker, Geert R D'Haens, Krisztina B Gecse, Michael F Gerhards, Jeroen M Jansen, Marcel G W Dijkgraaf, Jarmila D W van der Bilt, Marco W Mundt, Antonino Spinelli, Silvio Danese, Willem A Bemelman, Christianne J Buskens

Publikováno v: The Lancet Gastroenterology and Hepatology, 7(7), 617-626. Elsevier Ltd
Meima-van Praag, E M, van Rijn, K L, Wasmann, K A T G M, Snijder, H J, Stoker, J, D'Haens, G R, Gecse, K B, Gerhards, M F, Jansen, J M, Dijkgraaf, M G W, van der Bilt, J D W, Mundt, M W, Spinelli, A, Danese, S, Bemelman, W A & Buskens, C J 2022, ' Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II) : a patient preference randomised trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 7, pp. 617-626 . https://doi.org/10.1016/S2468-1253(22)00088-7

Background: Guidelines on Crohn's perianal fistulas recommend anti-tumour necrosis factor (TNF) treatment and suggest considering surgical closure for patients with surgically amenable disease. However, long-term outcomes following these two strategi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd3f8e5b2dc14438623e37d83c4efc8b
http://www.scopus.com/inward/record.url?scp=85129321342&partnerID=8YFLogxK

Impact of Fibroscan® on management of chronic viral hepatitis in clinical practice

Autor: Renske E. Blom, Karel J. van Erpecum, Claudia Verveer, Hanneke van Soest, Robert E. de Knegt, Joop E. Arends, Dietje E. Fransen van de Putte, Eveline P. Mauser-Bunschoten, Marco W. Mundt

Publikováno v: Annals of Hepatology, Vol 10, Iss 4, Pp 469-476 (2011)

Background. Liver stiffness measurement (LSM) using Fibroscan® is an increasingly popular non-invasive me¬thod for quantifying liver fibrosis in patients with chronic viral hepatitis. We aimed to explore potential im¬pact of Fibroscan® on clinica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d55853b83c33689ab071c221d4f2522
https://doi.org/10.1016/s1665-2681(19)31514-5

Fecal immunochemical testing results and characteristics of colonic lesions

Autor: Ernst J. Kuipers, Thomas R. de Wijkerslooth, Sascha C. van Doorn, An K. Stroobants, Inge Stegeman, Paul Fockens, Evelien Dekker, Marco W. Mundt, Patrick M.M. Bossuyt

Publikováno v: Endoscopy, 47(11), 1011-1017. Georg Thieme Verlag
Endoscopy, 47(11), 1011. Georg Thieme Verlag

Background and study aims: Fecal immunochemical tests (FIT) are used to detect blood in feces, which might indicate the presence of colorectal neoplasia. The aim of this study was to investigate whether FIT results vary depending on the characteristi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a06123d4063574d0419f5cc773cd2469
https://pure.amc.nl/en/publications/fecal-immunochemical-testing-results-and-characteristics-of-colonic-lesions(305baa46-5a52-4c62-8bc9-f790e96df69a).html

The accuracy of polyp assessment during colonoscopy in FIT-screening is not acceptable on a routine basis

Autor: Evelien Dekker, Inge Stegeman, Patrick M.M. Bossuyt, Paul Fockens, Marco W. Mundt, Sascha C. van Doorn, Rosalie C. Mallant-Hent, Manon van der Vlugt

Publikováno v: Endoscopy international open, 2(3), E127-32. Georg Thieme Verlag
Endoscopy International Open

Background: During colonoscopy, correct assessment of polyps is important. Recognition of early carcinomas is needed for tailor-made treatment and avoidance of unnecessary complications. Moreover, accurate diagnosis of diminutive lesions could result

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727bab473180cc15e2c4f780aca38084
https://pure.amc.nl/en/publications/the-accuracy-of-polyp-assessment-during-colonoscopy-in-fitscreening-is-not-acceptable-on-a-routine-basis(8754dc5b-7a67-42ed-be7f-cb1bec529d29).html

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round

Autor: Karin de Winter de Groot, Marco W. Mundt, Paul Fockens, Patrick M.M. Bossuyt, Rosalie C. Mallant-Hent, An K. Stroobants, Evelien Dekker, Inge Stegeman, Thomas R. de Wijkerslooth

Publikováno v: BMC Gastroenterology, Vol 12, Iss 1, p 73 (2012)
BMC gastroenterology, 12(1). BioMed Central
BMC Gastroenterology

Background Colorectal cancer (CRC) is the most common cancer in Europe with a mortality rate of almost 50%. The prognosis of patients is largely determined by the clinical and pathological stage at the time of diagnosis. Population screening has been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18766fafd88c3d5c7e23e0aec9b2e459
http://www.biomedcentral.com/1471-230X/12/73